The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for H Meudal


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities.EBI
University of Paris
Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach.EBI
University of Paris
Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme.EBI
University of Paris
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells.EBI
University of Paris
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.EBI
University of Paris
Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.EBI
University of Paris
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor Agonists.EBI
Paris-Sud University
Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode.EBI
University of Paris
Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.EBI
University of Paris
Synthesis and anti-HIV-1 integrase activity of modified dinucleotides.EBI
Affiliated With The University of Orl£Ans and With Inserm Rue Charles Sadron
Quinoxaline compounds and uses thereofBDB
Millennium Pharmaceuticals